Castle Biosciences, Inc.
CSTL
$21.98
$0.843.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 18.25M | 6.08M | -3.10M | -30.80M | -57.47M |
| Total Depreciation and Amortization | 16.00M | 13.45M | 13.09M | 12.78M | 12.33M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.75M | 48.00M | 42.80M | 44.78M | 46.14M |
| Change in Net Operating Assets | -14.13M | -8.44M | -12.02M | -13.78M | -6.63M |
| Cash from Operations | 64.87M | 59.09M | 40.76M | 12.98M | -5.63M |
| Capital Expenditure | -28.33M | -24.55M | -20.63M | -19.44M | -13.62M |
| Sale of Property, Plant, and Equipment | 18.00K | 14.00K | 12.00K | 13.00K | 13.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.83M | -39.04M | -37.88M | -33.05M | -2.58M |
| Cash from Investing | -50.14M | -63.58M | -58.50M | -52.47M | -16.18M |
| Total Debt Issued | 10.00M | 10.00M | 10.00M | 10.00M | -- |
| Total Debt Repaid | -97.00K | -107.00K | -119.00K | -143.00K | -142.00K |
| Issuance of Common Stock | 5.00M | 4.73M | 2.93M | 3.06M | 2.98M |
| Repurchase of Common Stock | -8.76M | -6.40M | -5.38M | -5.29M | -5.13M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.14M | 8.23M | 7.43M | 7.62M | -2.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.87M | 3.74M | -10.30M | -31.87M | -24.11M |